Skip to content
cariprazine

Structure via PubChem · Public domain (PubChem)

EntityQ2938837· pop 25· linked from 1,678 articles

cariprazine

Sign in to save

Also known as RGH 188, RGH-188, Vraylar®, trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hydrochloride, Kariprazin

Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, which is used in the treatment of schizophrenia and bipolar disorder. It is also prescribed as an add-on treatment for bipolar depression and major depressive disorder. Cariprazine acts primarily as a D3 and D2 receptor partial agonist, with a preference for the D3 receptor. It is a partial agonist at the serotonin 5-HT1A receptor and acts as an antagonist at 5-HT2B and 5-HT2A receptors. It is taken by mouth. The most prevalent side effects include nausea, mild sedation, fatig

In the Vinony graph

Within Vinony's link graph, cariprazine is referenced by 1,678 other articles, and connects out to fluphenazine, zuclopenthixol and flupentixol.

It is catalogued under topics including 2,3-Dichlorophenylpiperazines, Atypical antipsychotics and Chemicals using indexlabels.

Its subject is documented across 24 Wikipedia language editions.

Key facts

Drug.image
Cariprazine.svg
Drug.image_class
skin-invert-image
Drug.width
250
Drug.image2
Cariprazine ball-and-stick model.png
Drug.image_class2
bg-transparent
Drug.width2
250
Drug.tradename
Vraylar, Reagila, Symvenu
Drug.DailyMedID
Cariprazine
Drug.licence_US
Cariprazine
Drug.pregnancy_AU
D
Drug.routes_of_administration
By mouth
Drug.class
Atypical antipsychotic
Drug.ATC_prefix
N05
Drug.ATC_suffix
AX15
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_UK
POM
Drug.legal_US
Rx-only

via Wikipedia infobox

Chemical data

Formula
C21H32Cl2N4O
Molecular weight
427.4 g/mol
IUPAC name
3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea
SMILES
CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl
InChIKey
KPWSJANDNDDRMB-UHFFFAOYSA-N
XLogP
4.3
Polar surface area
38.8 Ų
H-bond donors
1
H-bond acceptors
3
Formal charge
0

via PubChem

Wikidata facts

Mass
426.1953
Show 6 more facts
chemical formula
C₂₁H₃₂Cl₂N₄O
World Health Organisation international non-proprietary name
cariprazine
canonical SMILES
CN(C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl)C
isomeric SMILES
CN(C(=O)N[C@H]1CC[C@@H](CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl)C
Commons category
Cariprazine
defined daily dose
3
Sources (7)

via Wikidata · CC0

~11 min read

Encyclopedic overview

7 sections
Contents
  • Medical uses
  • Side effects
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Research
  • References

Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, which is used in the treatment of schizophrenia and bipolar disorder. It is also prescribed as an add-on treatment for bipolar depression and major depressive disorder. Cariprazine acts primarily as a D3 and D2 receptor partial agonist, with a preference for the D3 receptor. It is a partial agonist at the serotonin 5-HT1A receptor and acts as an antagonist at 5-HT2B and 5-HT2A receptors. It is taken by mouth. The most prevalent side effects include nausea, mild sedation, fatigue, diabetes regardless of weight changes, and dizziness. At higher dosages, there is an increased risk for restlessness, insomnia, and tremors.

thumb|Bottles of 3mg and 4.5mg Vraylar (cariprazine) capsules showing 3mg capsules below

Excerpted from Wikipedia’s “cariprazine” article, available under the CC BY-SA 4.0 licence.

Gallery (3)

Connections

Categories